Skip to main content
Clinical Trials/NCT00724828
NCT00724828CompletedNot Applicable

An Evaluation of Streptococcus Pneumoniae Serotype Carriage Rate For Nasopharyngeal Carriage in Filipino Children Attending Well Baby Clinic in Hospitals and Primary Care Centers

Wyeth is now a wholly owned subsidiary of Pfizer0 sites500 target enrollmentStarted: May 2005Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
500
Primary Endpoint
Streptococcus pneumoniae serotype carriage rate based on a nasopharyngeal swab.

Study Overview

Brief Summary

Evaluation of the carriage rate of Streptococcus pneumoniae in the nasopharynx of healthy children and the carriage rate and distribution of Streptococcus pneumoniae serotypes

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
2 Months to 5 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy children aged between 2 months and 5 years attending the well baby clinic in hospital.
  • Informed consent obtained from parents or legal guardian.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Streptococcus pneumoniae serotype carriage rate based on a nasopharyngeal swab.

Time Frame: 1 day

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Sponsor Class
Industry

Similar Trials

Study Evaluating Streptococcus Pneumoniae... | Clinical Trial